23andMe Holding Co. Class A Common Stock (ME) Social Stream



23andMe Holding Co. Class A Common Stock (ME): $2.81

-0.06 (-2.09%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

23ANDME HOLDING CO (ME) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering 23ANDME HOLDING CO.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-07-12 1 $14 $14 $14 $2.92 379.45%
2021-11-15 1 $13 $13 $13 $2.92 345.21%
2021-12-20 1 $9 $9 $9 $2.92 208.22%
2022-05-27 1 $3 $3 $3 $2.92 2.74%
2022-11-09 2 $6 $3 $4.5 $2.92 54.11%

The Trend in the Analyst Price Target


Over the past 14 months, ME's average price target has gone down $8.5.

ME reports an average of 42.39% for its upside potential over the past 46 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-12-20 1 9 9 9.0 6.61 36.16%
2022-05-27 1 3 3 3.0 2.86 4.9%
2022-09-23 2 6 3 4.5 2.77 62.45%
2022-11-09 2 6 3 4.5 2.71 66.05%

ME Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
2 1 0 1 0 0 2

The Trend in the Broker Recommendations


Over the past 26 weeks, ME's average broker recommendation rating improved by 1.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In the context of all US stocks, 23ANDME HOLDING CO's number of analysts covering the stock is greater than 3.68% of them.
  • In the context of all US stocks, 23ANDME HOLDING CO's variance in analysts' estimates is lower than 26.54% of them.
  • In terms of how 23ANDME HOLDING CO fares relative to stocks in the mid market cap category, note that its average analyst price target is higher than 40.79% of that group.
  • ME has a higher upside potential (average analyst target price relative to current price) than 339.95% of stocks in the mid market cap category.

Stocks similar to 23ANDME HOLDING CO in the Pharmaceutical Products industry regarding analyst recommendations and price targets are STTK, ROIV, and PRAX.

Make investment decisions regarding ME using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.6451 seconds.